Reference

1. Kharroubi AT, Darwish HM. Diabetes mellitus: The epidemic of the century. World J Diabetes. 2015 Jun 25;6(6):850-67. doi: 10.4239/wjd.v6.i6.850. PMID: 26131326; PMCID: PMC4478580
2. Sapra A, Bhandari P. Diabetes. [Updated 2023 May 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan
3. Klein BE, Klein R, Moss SE, Cruickshanks KJ. Parental history of diabetes in a population-based study. Diabetes Care. 1996 Aug;19(8):827-30
4. Oparil S, Acelajado MC, Bakris GL, Berlowitz DR, Cífkova R, Dominiczak AF, Grassi G, Jordan J, Poulter NR, Rodgers A, Whelton PK. Hypertension. Nat Rev Dis Primers. 2018 Mar 22;4:18014. doi: 10.1038/nrdp.2018.14. PMID: 29565029; PMCID: PMC6477925.
5. Bindroo S, Quintanilla Rodriguez BS, Challa HJ. Renal Failure. [Updated 2022 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan
6. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005 Nov;16(11):3365-70 
7. Dapagliflozin Tablet -Uses, Interaction, Mechanism of Action , DRUGBANK  Online ,by drugbank.com
8. Dhillon S. Dapagliflozin: A Review in Type 2 Diabetes. Drugs. 2019 Jul;79(10):1135-1146. doi 10.1007/s40265-019-01148-3. Erratum in: Drugs. 2019 Dec;79(18):2013. PMID: 31236801; PMCID: PMC6879440.
9.  Martha K Nicholson, Randa Ghazal Asswad & John PH Wilding .(2021) Dapagliflozin for the treatment of type 2 diabetes mellitus – an update, Expert Opinion on pharmacotherapy, 22:17, 2303-2310, DOI:10.1080/14656566.2021.1953471    
10. Balakumar P, Sundram K, Dhanaraj S.(2014) Dapagliflozin: glucuretic action and beyond. Pharmacol Res 82: 34–39.
11.  Mudaliar S, Henry R, Boden G, Smith S, Chalamandaris A, Duchesne D, et al. (2014) Changes in insulin sensitivity and insulin secretion with the sodiumglucose cotransporter 2 inhibitor dapagliflozin. Diabetes Technol Ther 16: 137–144 
12.  Solomon, Scott D , McMurray, John J.V, Claggett, Brian de Boer, Rudolf A, DeMets, David, Hernandez, Adrian F, Inzucchi, Silvio E, Kosiborod, Mikhail N, Lam, Carolyn S.P, Martinez, Felipe ,Shah, Sanjiv J, Desai, Akshay S, Jhund, Pardeep S, Belohlavek, Jan Chiang, Chern-En , Borleffs, C,Jan Willem,  Comin-Colet, Josep , Dobreanu, Dan, Drozdz, Jaroslaw, Fang, James C, Alcocer-Gamba, Marco Antonio, Al Habeeb, Waleed , Han, Yaling ,Cabrera Honorio, Jose Walter and Janssens, Stefan P. and Katova, Tzvetana and Kitakaze, Masafumi and Merkely,Meara, Eileen, Saraiva, Jose Francisco Kerr, Tereshchenko, Sergey N, Thierer, Jorge ,Vaduganathan, Muthiah , Vardeny, Orly, Verma, Subodh ,Pham, Vinh Nguyen, Wilder, Ulrica, Zaozerska, Natalia ,Bachus, Erasmus ,Lindholm, Daniel and Petersson, Magnus and Langkilde, Anna Maria,Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction,New England Journal of Medicine,387,12,1089-1098,2022,doi :10.1056/NEJMoa2206286, PMID: 36027570
13. Gupta M, Rao S, Manek G, Fonarow GC, Ghosh RK. The Role of Dapagliflozin in the Management of Heart Failure: An Update on the Emerging Evidence. Ther Clin Risk Manag. 2021;17:823-830
14. Heerspink, Hiddo J.L. and Stefnsson, Bergur V. and Correa-Rotter, Ricardo and Chertow, Glenn M. Greene, Tom, Hou, Fan-Fan, Mann, Johannes F.E. McMurray, John J.V, Lindberg, Magnus, Rossing, Peter, C. David ,Toto, Roberto D. Langkilde, Anna-Maria, Wheeler, David C. Dapagliflozin in Patients with Chronic Kidney Disease, New England Journal of Medicine,383,15,1436-1446,2020,doi = {10.1056/NEJMoa2024816} note ={PMID: 32970396}
15. McMurray JJV, Wheeler DC, Stefansson BV, Jongs N, Postmus D, Correa-Rotter R, Chertow GM, Greene T, Held C, Hou FF, Mann JFE, Rossing P, Sjostrom CD, Toto RD, Langkilde AM, Heerspink HJL; DAPA-CKD Trial Committees and Investigators. Effect of Dapagliflozin on Clinical Outcomes in Patients With Chronic Kidney Disease, With and Without Cardiovascular Disease. Circulation. 2021 Feb 2;143(5):438-448. doi: 10.1161/CIRCULATIONAHA.120.051675. Epub 2020 Nov 13. PMID: 33186054.
16. Dapagliflozin and metformin (oral route), drugs and supplements, MAYO CLINIC, by drug information provided by Meratives, Micromedex 
17. Dapagliflozin (Rx), Drugs and Diseases,by Medscape.com 
18. Dapagliflozin (Farmiga), DRUGS AND SUPPLEMENTS, by EVERYDAY HEALTH, everyday .com
19. Dapagliflozin, Medline Plus Trusted Health Information For You,NIH, National Library of Medicine by Medline plus.com